<SEC-DOCUMENT>0001615219-19-000047-index.html : 20190918 <SEC-HEADER>0001615219-19-000047.hdr.sgml : 20190918 <ACCEPTANCE-DATETIME>20190918165545 ACCESSION NUMBER: 0001615219-19-000047 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20190719 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190918 DATE AS OF CHANGE: 20190918 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001615219 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465087339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36812 FILM NUMBER: 191100271 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 346-772-0346 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 FORMER COMPANY: FORMER CONFORMED NAME: Flex Pharma, Inc. DATE OF NAME CHANGE: 20140730 </SEC-HEADER> <DOCUMENT> <TYPE>8-K/A <SEQUENCE>1 <FILENAME>slrx8kano1.htm <DESCRIPTION>8-K/A <TEXT> Document 1 - file: slrx8kano1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>2 <FILENAME>a231weaverconsentng.htm <DESCRIPTION>EX-23.1 <TEXT> Document 2 - file: a231weaverconsentng.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>3 <FILENAME>a991salarius12-31x18fs.htm <DESCRIPTION>EX-99.1 <TEXT> Document 3 - file: a991salarius12-31x18fs.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>4 <FILENAME>a992salarius6-30x19fs.htm <DESCRIPTION>EX-99.2 <TEXT> Document 4 - file: a992salarius6-30x19fs.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.4 <SEQUENCE>5 <FILENAME>a994proformafs.htm <DESCRIPTION>EX-99.4 <TEXT> Document 5 - file: a994proformafs.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.3 <SEQUENCE>6 <FILENAME>a993salarius3-31x19fs.htm <DESCRIPTION>EX-99.3 <TEXT> Document 6 - file: a993salarius3-31x19fs.htm
</DOCUMENT> </SEC-DOCUMENT>